by As women began having babies later in life, the number of patients undergoing in vitro fertilization treatment has increased significantly.
Medical treatment can be life-changing, but it also comes with a price, as some couples go deep into debt to pay for medical care that health insurance doesn’t always cover. Some research has questioned the effectiveness of newer aspects of fertility treatment, such as genetic testing, and some patients have filed lawsuits. claiming that faulty chemicals destroyed their embryos. Private equity firms, seeing the rapid growth of the industry, have been buying some of the largest fertility clinics in the country.
The New York Times is looking to hear from readers who can share their recent experiences with in vitro fertilization treatment. Listening to patients helps us better understand where we should focus our reporting.
We will not publish any part of your response to this questionnaire without speaking to you first. We will not share your contact information outside of the Times newsroom and will use it only to contact you. If you feel more comfortable sharing your story with us anonymously, please visit our advice page.
